# ra-enrich-01 — final adjudication ONLY. Repair nothing.

Six of the seven items now pass both lanes. One remains:

**`thm-standard-maclaurin-expansions`** — DeepSeek **PASS**, Terra **REJECT**:

> Step 2.2 claims 1/(n+1) tends to 0 by L23, but L23 only supplies a single n
> for each positive epsilon. It gives neither an eventual bound nor convergence
> of the reciprocal sequence, so the ratio-test limit is not licensed.

## Your task: adjudicate this rejection. Do not repair it.

The stopping rule you accepted in round 3 now fires. This is the **fifth**
distinct Terra objection on this item, it is on a step unchanged since it was
authored, and it comes after your exhaustive round-3 notation audit. Round 4's
override applied only because that defect was a regression we introduced; this
one is not.

Assess Terra's objection on the merits and record the outcome:

- Is the claim TRUE? (Archimedean gives some $N$ with $1/N<\varepsilon$;
  monotonicity of $1/(n+1)$ then gives the eventual bound.)
- Is the gap closable by a competent reader in thirty seconds?
- Is it a `confirmed_nonfatal`, or is it a `false_positive` because `[L23]` or a
  neighbouring fact already supplies what is needed?

**`confirmed_fatal` is the only outcome that would block publication**, so if you
believe this is genuinely fatal — the ratio-test limit truly unlicensed and the
binomial radius therefore unproved — say so plainly and I will stop the publish.
Anything else closes it.

Write the row to `research/ra-enrich-01-adjudications.jsonl` against the current
`item_sha256`, and a short closing section in
`research/ra-enrich-01-alpha-report.md` recording: this outcome, the final
per-item judge state, and your one-paragraph view for the owner on whether this
item should later be SPLIT — six collated families in one item, the generalized
binomial in another. It has now exhausted DeepSeek's 40,000-token reasoning
budget TWICE (round 3 and round 4, rescued by retry both times), drawn five
distinct objections where the other six items drew six between them, and needed
a nine-phase restratification to make its own internal citations expressible.
That reviewability argument is separate from the defect-distribution argument you
made against splitting in round 3; weigh both and give the owner your view.

Do not edit any item file. Do not write `verification.judge` or
`verification.audited`. Do not publish.
